In December 2020, DOJ filed a civil complaint against Walmart, Inc. for unlawfully distributing and dispensing controlled substances from its pharmacies. In the complaint, DOJ alleges that Walmart’s conduct resulted in hundreds of thousands of violations of the Controlled Substances Act. DOJ is seeking injunctive relief and civil penalties which could amount to billions of dollars.